Cargando…
Closed-loop insulin delivery for treatment of type 1 diabetes
Type 1 diabetes is one of the most common endocrine problems in childhood and adolescence, and remains a serious chronic disorder with increased morbidity and mortality, and reduced quality of life. Technological innovations positively affect the management of type 1 diabetes. Closed-loop insulin de...
Autores principales: | Elleri, Daniela, Dunger, David B, Hovorka, Roman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3229449/ https://www.ncbi.nlm.nih.gov/pubmed/22071283 http://dx.doi.org/10.1186/1741-7015-9-120 |
Ejemplares similares
-
Closed-Loop Insulin Delivery During Pregnancy Complicated by Type 1 Diabetes
por: Murphy, Helen R., et al.
Publicado: (2011) -
Pharmacokinetics of diluted (U20) insulin aspart compared with standard (U100) in children aged 3–6 years with type 1 diabetes during closed-loop insulin delivery: a randomised clinical trial
por: Ruan, Yue, et al.
Publicado: (2014) -
Closed-Loop Basal Insulin Delivery Over 36 Hours in Adolescents With Type 1 Diabetes: Randomized clinical trial
por: Elleri, Daniela, et al.
Publicado: (2013) -
Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies
por: Hovorka, Roman, et al.
Publicado: (2011) -
Feasibility of overnight closed-loop therapy in young children with type 1 diabetes aged 3–6 years: comparison between diluted and standard insulin strength
por: Elleri, Daniela, et al.
Publicado: (2014)